1 Oct 2020 07:17
FORM 8.3
Amendment to Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 28 September 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
2,288,462 | 1.78% | 463,830 | 0.36% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
355,000 | 0.28% | 388,524 | 0.30% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
(4) | TOTAL: |
|
|
|
|
2,643,462 | 2.05% | 852,354 | 0.66% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 7 | 205.9050 USD |
Purchase | 8 | 206.1300 USD |
Purchase | 16 | 206.9475 USD |
Purchase | 58 | 205.6800 USD |
Purchase | 85 | 204.8500 USD |
Purchase | 96 | 201.1800 USD |
Purchase | 100 | 202.7600 USD |
Purchase | 100 | 207.4000 USD |
Purchase | 100 | 207.8400 USD |
Purchase | 100 | 206.3900 USD |
Purchase | 100 | 206.1600 USD |
Purchase | 100 | 205.9000 USD |
Purchase | 102 | 205.9388 USD |
Purchase | 110 | 202.9186 USD |
Purchase | 202 | 206.4839 USD |
Purchase | 300 | 201.7733 USD |
Purchase | 300 | 205.4333 USD |
Purchase | 346 | 202.8802 USD |
Purchase | 363 | 207.1257 USD |
Purchase | 367 | 206.1268 USD |
Purchase | 377 | 203.6636 USD |
Purchase | 386 | 205.0134 USD |
Purchase | 393 | 206.8652 USD |
Purchase | 397 | 207.0132 USD |
Purchase | 400 | 203.6975 USD |
Purchase | 422 | 206.0816 USD |
Purchase | 483 | 204.2953 USD |
Purchase | 486 | 205.5467 USD |
Purchase | 588 | 206.8417 USD |
Purchase | 588 | 206.4829 USD |
Purchase | 686 | 205.2494 USD |
Purchase | 837 | 207.5215 USD |
Purchase | 956 | 206.6062 USD |
Purchase | 956 | 207.3602 USD |
Purchase | 1,057 | 205.6401 USD |
Purchase | 1,184 | 207.4494 USD |
Purchase | 1,258 | 207.6501 USD |
Purchase | 1,564 | 206.1802 USD |
Purchase | 2,137 | 207.2824 USD |
Purchase | 3,683 | 206.8576 USD |
Purchase | 4,609 | 205.6621 USD |
Purchase | 5,969 | 207.2997 USD |
Purchase | 6,359 | 206.7307 USD |
Purchase | 11,326 | 207.0633 USD |
Purchase | 15,455 | 205.7840 USD |
Purchase | 20,393 | 206.8500 USD |
Sale | 1 | 207.2100 USD |
Sale | 38 | 206.8600 USD |
Sale | 100 | 206.8200 USD |
Sale | 100 | 205.5000 USD |
Sale | 100 | 206.7550 USD |
Sale | 161 | 207.3368 USD |
Sale | 169 | 206.5194 USD |
Sale | 200 | 204.3900 USD |
Sale | 200 | 205.5225 USD |
Sale | 341 | 204.4753 USD |
Sale | 548 | 204.2086 USD |
Sale | 569 | 205.0194 USD |
Sale | 587 | 206.8411 USD |
Sale | 957 | 205.5237 USD |
Sale | 1,073 | 205.9366 USD |
Sale | 1,260 | 206.0037 USD |
Sale | 1,507 | 206.4172 USD |
Sale | 3,630 | 206.8496 USD |
Sale | 5,987 | 206.8500 USD |
Sale | 6,795 | 207.0949 USD |
Sale | 7,992 | 205.7480 USD |
Sale | 10,939 | 205.5643 USD |
Sale | 15,272 | 206.8143 USD |
Sale | 25,647 | 207.1477 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | NO |
Date of disclosure: | 1 Oct 2020 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20200930006047/en/
Copyright Business Wire 2020